Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.1B | 2.3B | 2.5B | 3.7B |
| Cost of revenue | 544M | 506M | 427M | 465M |
| Gross profit | 2.6B | 1.8B | 2.1B | 3.3B |
| Operating expense | ||||
| Research & development | 610M | 568M | 538M | 524M |
| Selling general and admin | 998M | 857M | 795M | 849M |
| Other operating expenses | 332M | 303M | 290M | 369M |
| Operating income | 612M | 38M | 430M | 1.5B |
| Non operating interest income | ||||
| Income | 190M | 173M | 183M | 207M |
| Expense | — | — | — | — |
| Other income expense | -23M | -38M | 9M | 3M |
| Pretax income | 779M | 173M | 622M | 1.7B |
| Tax provision | 137M | 19M | 161M | 367M |
| Net income | 642M | 154M | 461M | 1.4B |
| Basic EPS | 1.0 | 0.3 | 0.7 | 2.2 |
| Diluted EPS | 1.0 | 0.2 | 0.7 | 2.1 |
| Basic average shares | 615M | 621M | 625M | 631M |
| Diluted average shares | 626M | 632M | 636M | 642M |
| EBITDA | 612M | 63M | 452M | 1.5B |
| Net income from continuing op. | 642M | 154M | 461M | 1.4B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |